搜索此博客

2023年3月28日星期二

Lenacapavir: An Innovative Solution for HIV Treatment

Lenacapavir (CAS No. 2189684-44-2) is a long-acting antiretroviral drug that has shown promising results in treating HIV-1 infections. It is an integrase inhibitor that works by blocking the action of the integrase enzyme, preventing the virus from replicating and infecting healthy cells. Lenacapavir is a potent active pharmaceutical ingredient with a chemical formula of C39H32ClF10N7O5S2 and an assay purity of 99.9%.

EOS MedChem, a GMP-certified manufacturer, produces Lenacapavir in batch sizes of 1-10kg. With a stock of 550g, they are able to meet the demands of customers around the world. The company also offers intermediates commercial production to support the development of other HIV therapies.


One of the main advantages of Lenacapavir is its long-acting nature, allowing for a once-a-month injection instead of the daily oral pills required for most antiretroviral therapies. This reduces the burden on patients and improves medication adherence, which is critical for HIV treatment success.

In addition, Lenacapavir has shown a high barrier to resistance, meaning it can still be effective even in the presence of drug-resistant strains of HIV. This is a significant benefit as drug resistance is a major challenge in HIV treatment.

Overall, Lenacapavir offers a promising solution for the treatment of HIV-1 infections. With its long-acting nature, high barrier to resistance, and the support of GMP-certified manufacturers like EOS MedChem, it has the potential to significantly improve the lives of people living with HIV.

Ms Nina
D-U-N-S Number 703 340 474
EOS Med Chem, Medicinal Chemical is Big
執大象,天下往,往而無害,安平泰
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com 
Youtube: https://youtu.be/r5cJdXKNXHk.